Related Experiment Video
Updated: Mar 19, 2026
06:35
Examining Recall Memory in Infancy and Early Childhood Using the Elicited Imitation Paradigm
Published on: April 28, 2016
35.6K
Improving Memory and Cognition in Individuals with Down Syndrome
1Department of Neurosciences, University of California, San Diego, 9500 Gilman Drive #0949, La Jolla, CA, 92093-0949, USA. mrafii@ucsd.edu.
CNS Drugs
|June 9, 2016
Summary
Down syndrome (DS) research explores new treatments for intellectual disability (ID) and Alzheimer's disease (AD). Clinical trials are advancing, focusing on targeted compounds and effective study designs for the DS population.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Down syndrome (DS), primarily caused by trisomy 21, is the leading genetic cause of intellectual disability (ID).
- Individuals with DS exhibit high rates of Alzheimer's disease (AD) neuropathology and dementia, with nearly 60% symptomatic by age 65.
- Current therapeutic options for ID in DS are absent, and AD treatments are limited.
Purpose of the Study:
- To review recent progress in developing therapeutic compounds for intellectual disability and Alzheimer's disease in individuals with Down syndrome.
- To discuss essential considerations for designing and conducting clinical trials targeting these conditions in the DS population.
Main Methods:
- Review of recent studies and animal models of DS relevant to therapeutic targets for ID and AD.
- Analysis of drug development pathways, including target and compound selection.
- Examination of clinical trial design and operational aspects for assessing efficacy in the DS population.
Main Results:
- Advances in understanding the molecular basis of ID and AD pathogenesis in DS offer potential therapeutic targets.
- Animal models provide a basis for translating specific compounds into human clinical trials.
- Progress is being made in identifying and developing compounds for ID and AD in DS.
Conclusions:
- Translational research in DS is progressing, with promising compounds identified for ID and AD.
- Careful consideration of clinical trial design, including cognitive assessment, is crucial for successful drug development in DS.
- Future research and clinical trials hold potential for improved treatments for individuals with Down syndrome.
Related Concept Videos
01:30Cognitive Development During Adulthood
1.1K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.1K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
807
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
807
01:30Information Processing Approach
719
The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
719
01:22Chunking and Rehearsal in Sensory Memory
707
Improving short-term memory can be achieved through techniques like chunking and rehearsal. Chunking involves organizing information into larger, more manageable units. This technique is particularly useful for information that exceeds the typical memory span of between five and nine items. For instance, logging into an online account with a password like "ta89vq0179gz" involves grouping letters and numbers into three chunks—ta89, vq01, and 79gz. It makes large amounts of...
707
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:14Role of Cerebellum and Prefrontal Cortex in Memory
1.4K
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
1.4K